Shanghai Ji Ai Genetics and IVF Institute, Obstetrics and Gynecology Hospital, Fudan University, 252 Dalin Road Shanghai 200011, China.
Shanghai Biotecan Pharmaceuticals Co., Ltd. Shanghai, China; Shanghai Zhangjiang Institute of Medical Innovation Shanghai, China.
Reprod Biomed Online. 2022 Oct;45(4):643-651. doi: 10.1016/j.rbmo.2022.06.007. Epub 2022 Jun 17.
Can models based on artificial intelligence predict embryonic ploidy status or implantation potential of euploid transferred embryos? Can the addition of clinical features into time-lapse monitoring (TLM) parameters as input data improve their predictive performance?
A single academic fertility centre, retrospective cohort study. A total of 773 high-grade euploid and aneuploid blastocysts from 212 patients undergoing preimplantation genetic testing (PGT) between July 2016 and July 2021 were studied for ploidy prediction. Among them, 170 euploid embryos were single-transferred and included for implantation analysis. Five machine learning models and two types of deep learning networks were used to develop the predictive algorithms. The predictive performance was measured using the area under the receiver operating characteristic curve (AUC), in addition to accuracy, precision, recall and F1 score.
The most predictive model for ploidy prediction had an AUC, accuracy, precision, recall and F1 score of 0.70, 0.64, 0.64, 0.50 and 0.56, respectively. The DNN-LSTM model showed the best predictive performance with an AUC of 0.78, accuracy of 0.77, precision of 0.79, recall of 0.86 and F1 score of 0.83. The predictive power was improved after the addition of clinical features for the algorithms in ploidy prediction and implantation prediction.
Our findings emphasize that clinical features can largely improve embryo prediction performance, and their combination with TLM parameters is robust to predict high-grade euploid blastocysts. The models for ploidy prediction, however, were not highly predictive, suggesting they cannot replace preimplantation genetic testing currently.
基于人工智能的模型能否预测胚胎的倍性状态或整倍体转移胚胎的着床潜能?将临床特征添加到时间 lapse 监测(TLM)参数中作为输入数据能否提高其预测性能?
单家学术型生育中心的回顾性队列研究。对 2016 年 7 月至 2021 年 7 月期间进行植入前遗传学检测(PGT)的 212 名患者的 773 枚高级别整倍体和非整倍体囊胚进行了倍性预测研究。其中,170 枚整倍体胚胎为单胚胎移植,并纳入着床分析。使用五种机器学习模型和两种类型的深度学习网络来开发预测算法。除了准确性、精密度、召回率和 F1 评分外,还使用接收者操作特征曲线(ROC)下的面积(AUC)来衡量预测性能。
预测倍性的最具预测性的模型的 AUC、准确性、精密度、召回率和 F1 评分分别为 0.70、0.64、0.64、0.50 和 0.56。DNN-LSTM 模型表现出最佳的预测性能,AUC 为 0.78,准确性为 0.77,精密度为 0.79,召回率为 0.86,F1 评分为 0.83。在将临床特征添加到算法中进行倍性预测和着床预测后,预测能力得到了提高。
我们的研究结果强调,临床特征可以在很大程度上提高胚胎预测性能,并且它们与 TLM 参数的结合对于预测高级别整倍体囊胚是稳健的。然而,倍性预测模型的预测性能并不高,这表明它们目前不能替代植入前遗传学检测。